Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma. uri icon

Overview

publication date

  • January 1, 2021

Research

keywords

  • Lymphoma, Large B-Cell, Diffuse
  • Receptors, Chimeric Antigen

Identity

PubMed Central ID

  • PMC7776258

Scopus Document Identifier

  • 85094123549

Digital Object Identifier (DOI)

  • 10.3324/haematol.2019.243246

PubMed ID

  • 32079691

Additional Document Info

volume

  • 106

issue

  • 1